Skip to main content
OpenTrials
Completed

NCT Number: NCT05144971

StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation

The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician.

Completed

Looking for future studies?

Notify Me

Key information

About this study

To assess the performance of the StatStrip A Glucose/Creatinine assay in the hands of lay users on capillary whole blood obtained by finger stick and compare with the performance characteristics to a central laboratory traceable reference method.

To assess the Ease of Use of the StatStrip Glucose / Creatinine Meter System in the hands of the intended lay users. Lay users will be provided with all package insert sheets, a Quick Reference Guide and Instructions for Use (IFU) Manual. No training, coaching, or prompting will be provided to the lay users other than clarifying the protocol.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult subjects (≥ 18 years old) with diabetes.
  • Adult subjects (≥ 18 years old) with kidney diseases (CKD, ESRD) and/or in dialysis.
  • Adult subjects (≥ 18 years old) that are healthy.
  • Subjects willing to complete all study procedures.
  • Subjects whose pre-screen glucose or creatinine medical history is deemed of value by the study site
  • Subjects able to read, write, speak in English.

Exclusion criteria

  • Subjects unable to consent to participating in the study.
  • Subjects possessing a cognitive disorder or other condition, which, in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study.
  • Subjects taking prescription anticoagulants (such as Warfarin or Heparin) or has clotting problems that may prolong bleeding.
  • Subjects having hemophilia or any other bleeding disorder.
  • Subjects having an infection with a blood borne pathogen (e.g. HIV, hepatitis).
  • Subjects working for a medical device or diagnostic company.

Treatment and study plan

Glucose, Creatinine

Diagnostic Test

Compare diagnostic tests to reference methods

Primary outcomes

  1. Nova StatStrip A Glucose/Creatinine Meter System

    Time frame: 20 days

    The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician.

    The two parameters for the outcome measure in this study are glucose and creatinine. The unit of measure for glucose and creatinine is mg/dL and mmol/L, respectively.

Sponsors and collaborators

Lead sponsor

Nova Biomedical

Industry

Collaborators

  • Excellence Medical and Research

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Dec 6, 2021
Registry last updated
Sep 28, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.